Blue Trust Inc. Sells 374 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Blue Trust Inc. lowered its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 8.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,888 shares of the company’s stock after selling 374 shares during the period. Blue Trust Inc.’s holdings in Bath & Body Works were worth $151,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently modified their holdings of the stock. UMB Bank n.a. grew its holdings in Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after buying an additional 335 shares in the last quarter. True Wealth Design LLC boosted its position in shares of Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after acquiring an additional 1,054 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt boosted its position in shares of Bath & Body Works by 300.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after acquiring an additional 900 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new position in shares of Bath & Body Works in the third quarter valued at $39,000. Finally, Friedenthal Financial bought a new stake in Bath & Body Works in the fourth quarter worth $57,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Down 0.1 %

Shares of NYSE BBWI opened at $38.74 on Thursday. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99. The business has a fifty day simple moving average of $37.72 and a two-hundred day simple moving average of $33.65. The firm has a market cap of $8.39 billion, a PE ratio of 9.45, a price-to-earnings-growth ratio of 1.01 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.03. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. During the same period in the previous year, the company posted $0.48 earnings per share. On average, research analysts expect that Bath & Body Works, Inc. will post 3.26 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.07%. The ex-dividend date of this dividend was Friday, November 22nd. Bath & Body Works’s payout ratio is 19.51%.

Analyst Ratings Changes

BBWI has been the subject of several research reports. Telsey Advisory Group reiterated an “outperform” rating and set a $42.00 price objective on shares of Bath & Body Works in a research report on Monday, November 25th. TD Cowen increased their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a report on Thursday, December 12th. Morgan Stanley reduced their price objective on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a research note on Thursday, November 21st. Deutsche Bank Aktiengesellschaft raised their price objective on Bath & Body Works from $51.00 to $52.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Finally, JPMorgan Chase & Co. boosted their target price on Bath & Body Works from $39.00 to $41.00 and gave the company a “neutral” rating in a research report on Friday, January 24th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, Bath & Body Works currently has a consensus rating of “Moderate Buy” and an average target price of $43.19.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.